Page 1282 - Cote clinical veterinary advisor dogs and cats 4th
P. 1282

Melanoma  645.e1


           ADDITIONAL SUGGESTED                RELATED CLIENT EDUCATION
           READINGS                            SHEETS
  VetBooks.ir  Bergman  PJ,  et  al:  Development  of  a  xenogeneic   Consent to Administer Chemotherapy             Diseases and   Disorders
            DNA  vaccine  program  for  canine  malignant
                                               Consent  to  Perform  Fine-Needle  Aspiration
            melanoma at the Animal Medical Center. Vaccine
            24(21):4582-4585, 2006.
           Bergin  IL,  et  al:  Prognostic  evaluation  of  Ki67   of Masses
            threshold value in canine oral melanoma.  Vet
            Pathol 48:41-53, 2011.
           Boston  SE,  et  al:  Efficacy  of  systemic  adjuvant
            therapies administered to dogs after excision of
            oral malignant melanomas: 151 cases (2001-2012).
            J Am Vet Med Assoc 245(4):401-407, 2014.
           Brockley LK, et al: Malignant melanoma in 63 dogs
            (2001-2011): the effect of carboplatin chemotherapy
            on survival. N Z Vet J 61(1):25-31, 2013.
           Dank  G,  et  al:  Use  of  adjuvant  carboplatin  for
            treatment of dogs with oral malignant melanoma
            following surgical excision.  Vet Comp Oncol
            12(1):78-84, 2014.
           MacEwen EG , et al: Canine oral melanoma: compari-
            son of surgery versus surgery plus Corynebacterium
            parvum. Cancer Invest 4(5):397-402, 1986.
           Harvery HJ, et al: Prognostic criteria for dogs with
            oral  melanoma.  J  Am Vet  Med  Assoc  178:580,
            1981.
           Manley CA, et al: Xenogenic murine tyrosinase DNA
            vaccine for malignant melanoma of the digit of
            dogs. J Vet Intern Med 25(1):94-99, 2011.
           Marino  DJ,  et  al:  Evaluation  of  dogs  with  digit
            masses:  117  cases  (1981-1991).  J  Am  Vet  Med
            Assoc 207(6):726-728, 1995.
           Ottnod  JM,  et  al:  A  retrospective  analysis  of  the
            efficacy of Oncept vaccine for the adjunct treatment
            of  canine  oral  malignant  melanoma. Vet  Comp
            Oncol 11(3):219-29, 2013.
           Proulx DR, et al: A retrospective analysis of 140 dogs
            with oral melanoma treated with external beam
            radiation. Vet Radiol Ultrasound 44(3):352-359,
            2003.
           Rassnick KM, et al: Use of carboplatin for treatment
            of dogs with malignant melanoma: 27 cases (1989-
            2000). J Am Vet Med Assoc 218(9):1444-1448,
            2001.
           Smedley RC, et al: Prognostic markers for canine
            melanocytic neoplasms: a comparative review of
            the literature and goals for future investigation.
            Vet Pathol 48(1):54-72, 2011.
           Treggiari E, et al: A retrospective review of outcome
            and survival following surgery and adjuvant
            xenogeneic DNA vaccination in 32 dogs with oral
            malignant melanoma. J Vet Med Sci 78(5):845-850,
            2016.
           Tuohy JL, et al: Outcome following curative-intent
            surgery for oral melanoma in dogs: 70 cases (1998-
            2011). J Am Vet Med Assoc 245(11):1266-1273,
            2014.
           Verganti S, et al: Use of Oncept melanoma vaccine
            in 69 canine oral malignant melanomas in the UK.
            J Small Anim Pract 58(1):10-16, 2017.

















                                                      www.ExpertConsult.com
   1277   1278   1279   1280   1281   1282   1283   1284   1285   1286   1287